West Pharmaceutical Services | WST - Assets


West Pharmaceutical Services reported $4.08B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Align Technology USD 6.42B 103.41M Jun/2026
Baxter International USD 19.79B 55M Jun/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Cerus USD 221.86M 6.67M Dec/2025
Charles River Laboratories USD 7.53B 198.16M Jun/2026
Cooper Companies USD 12.48B 58.1M Mar/2026
Dentsply International USD 5.23B 200M Mar/2026
Haemonetics USD 2.4B 94.96M Mar/2026
ICU Medical USD 4.01B 36.74M Mar/2026
Insulet USD 3.17B 177.9M Jun/2026
Integra LifeSciences USD 3.56B 14.24M Jun/2026
IQVIA Holdings USD 29.88B 206M Jun/2026
J&J USD 201.06B 167M Jun/2026
Medtronic USD 91.48B 139M Dec/2025
Merit Medical Systems USD 2.86B 144.34M Jun/2026
Neogen USD 3.35B 13M Mar/2026
OraSure Technologies USD 379.17M 24M Mar/2026
Quidel USD 5.63B 140.6M Mar/2026
Repligen USD 2.95B 19.41M Jun/2026
Rockwell Medical USD 52.62M 1.34M Jun/2025
Solventum Corp USD 14.24B 146M Jun/2026
STAAR Surgical USD 451.12M 560K Mar/2026
Terumo JPY 2.31T 55.3B Mar/2026
Utah Medical Products USD 124.38M 1.84M Mar/2026
West Pharmaceutical Services USD 4.08B 33.4M Jun/2026